BMRN · Company research
BioMarin Pharmaceuticals Inc (BMRN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 56.22 | $11,386,910,380 | 10512905380.00 | 71.4452078723652 | — | — | 21.1834519233989039 | 1.8012440941444158 | 81.74790104312492372182 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.